Targeting Intracellular Bacteria with Dual Drug-loaded Lactoferrin Nanoparticles
ACS Infectious Diseases · 10.05.2024 · 10 (5) · 1696-1710
DOI: 10.1021/acsinfecdis.4c00045 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 05.04.2024. Verfasst von Moses Andima und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Delivery (DDEL), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research, Campus …. Hauptthemen laut MEDLINE: Lactoferrin, Nanoparticles, Staphylococcus aureus, Anti-Bacterial Agents. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alexander von Humboldt-Stiftung.
Abstract (Originalsprache)
Treatment of microbial infections is becoming daunting because of widespread antimicrobial resistance. The treatment challenge is further exacerbated by the fact that certain infectious bacteria invade and localize within host cells, protecting the bacteria from antimicrobial treatments and the host's immune response. To survive in the intracellular niche, such bacteria deploy surface receptors similar to host cell receptors to sequester iron, an essential nutrient for their virulence, from host iron-binding proteins, in particular lactoferrin and transferrin. In this context, we aimed to target lactoferrin receptors expressed by macrophages and bacteria; as such, we prepared and characterized lactoferrin nanoparticles (Lf-NPs) loaded with a dual drug combination of antimicrobial natural alkaloids, berberine or sanguinarine, with vancomycin or imipenem. We observed increased uptake of drug-loaded Lf-NPs by differentiated THP-1 cells with up to 90% proportion of fluorescent cells, which decreased to about 60% in the presence of free lactoferrin, demonstrating the targeting ability of Lf-NPs. The encapsulated antibiotic drug cocktail efficiently cleared intracellular Staphylococcus aureus (Newman strain) compared to the free drug combinations. However, the encapsulated drugs and the free drugs alike exhibited a bacteriostatic effect against the hard-to-treat Mycobacterium abscessus (smooth variant). In conclusion, the results of this study demonstrate the potential of lactoferrin nanoparticles for the targeted delivery of antibiotic drug cocktails for the treatment of intracellular bacteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Delivery (DDEL), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research, Campus E8.1, Saarbrücken 66123, Germany.
- Department of Chemistry, Faculty of Science and Education, Busitema University, P.O Box 236, Tororo 21435, Uganda.
- INM-Leibniz Institute for New Materials, Campus D2 2, Saarbrücken 66123, Germany.
- Department of Pharmacy, Saarland University, Saarbrücken 66123, Germany.
ORCID-Profile: Moses Andima
Förderung
- Alexander von Humboldt-Stiftung
Zitieren
APA
Andima, M., Boese, A., Paul, P., Koch, M., Loretz, B., & Lehr, C. M. (2024). Targeting Intracellular Bacteria with Dual Drug-loaded Lactoferrin Nanoparticles. ACS Infectious Diseases, 10(5), 1696-1710. https://doi.org/10.1021/acsinfecdis.4c00045
Vancouver
Andima M, Boese A, Paul P, Koch M, Loretz B, Lehr CM. Targeting Intracellular Bacteria with Dual Drug-loaded Lactoferrin Nanoparticles. ACS Infectious Diseases. 2024;10(5):1696-1710. doi:10.1021/acsinfecdis.4c00045
BibTeX
@article{Andima2024,
author = {Andima, Moses and Boese, Annette and Paul, Pascal and Koch, Marcus and Loretz, Brigitta and Lehr, Claus-Micheal},
title = {Targeting Intracellular Bacteria with Dual Drug-loaded Lactoferrin Nanoparticles},
journal = {ACS Infectious Diseases},
year = {2024},
volume = {10},
number = {5},
pages = {1696--1710},
doi = {10.1021/acsinfecdis.4c00045}
}
EUVIMED